Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

220
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
220
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43
Sampling Plans01:23

Sampling Plans

165
Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
165

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Adipokine, FAM19A5, Inhibits Neointima Formation After Injury Through Sphingosine-1-Phosphate Receptor 2.

Circulation·2018
Same author

Liquid-Crystalline Dynamic Networks Doped with Gold Nanorods Showing Enhanced Photocontrol of Actuation.

Advanced materials (Deerfield Beach, Fla.)·2018
Same author

KCa(H<sub>2</sub> O)<sub>2</sub> [Fe<sup>III</sup> (CN)<sub>6</sub> ]â‹…H<sub>2</sub> O Nanoparticles as an Antimicrobial Agent against Staphylococcus aureus.

Angewandte Chemie (International ed. in English)·2018
Same author

Warming deferentially altered multidimensional soil legacy induced by past land use history.

Scientific reports·2018
Same author

Advanced Modified Polyacrylonitrile Membrane with Enhanced Adsorption Property for Heavy Metal Ions.

Scientific reports·2018
Same author

Insulin-like growth factor 2 is a key mitogen driving liver repopulation in mice.

Cell death & disease·2018

Related Experiment Video

Updated: May 30, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

Basic Considerations for Data Pooling Strategy in Multi-Regional Clinical Trials (MRCTs).

Jiali Song1, Chen Ji2, Meng Chen3

  • 1Department of Biostatistics, School of Public Health, Peking University, Beijing, China.

Therapeutic Innovation & Regulatory Science
|January 25, 2025
PubMed
Summary
This summary is machine-generated.

This study addresses challenges in multi-regional clinical trials (MRCTs) in China, focusing on pooling strategies, effect modifiers, and statistical analysis for global drug development. It offers insights for harmonizing MRCT practices in China and East Asia.

Keywords:
Effect modifierICH E17Pooling strategySample size allocation

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.5K

Related Experiment Videos

Last Updated: May 30, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.5K

Area of Science:

  • Clinical Pharmacology
  • Regulatory Science
  • Biostatistics

Background:

  • China's National Medical Products Administration is adopting ICH E17 guidelines for multi-regional clinical trials (MRCTs).
  • Execution and conduct of MRCTs in China and East Asia face ambiguities regarding pooling, effect modifiers, and statistical analysis.
  • Alignment with global trial standards presents challenges for regional drug development.

Purpose of the Study:

  • To explore criteria for planning and conducting MRCTs within the Chinese context.
  • To address ambiguities in pooling strategies, identification of effect modifiers (EMs), statistical analysis, and sample size allocation.
  • To provide insights for domestic and international improvements in MRCT practices.

Main Methods:

  • Identifying intrinsic and extrinsic factors as potential effect modifiers (EMs) impacting drug efficacy in specific populations.
  • Implementing regional pooling strategies to assess population differences within East Asia when EMs are not identified.
  • Utilizing statistical models to estimate drug effects in pooled populations.

Main Results:

  • Defines criteria for determining effect modifiers in Chinese populations for MRCTs.
  • Outlines strategies for regional pooling and statistical analysis in the absence of identified EMs.
  • Clarifies sample size allocation considerations for East Asian MRCTs.

Conclusions:

  • This paper details MRCT practices in China, addressing key challenges in trial execution.
  • Provides practical insights for harmonizing MRCTs domestically and internationally.
  • Aims to improve the planning and conduct of future multi-regional clinical trials in the region.